The Danish Hip Arthroplasty Register

Per Hviid Gundtoft, Claus Varnum, Alma Becic Pedersen, Søren Overgaard, Per Hviid Gundtoft, Claus Varnum, Alma Becic Pedersen, Søren Overgaard

Abstract

Aim of database: The aim of the Danish Hip Arthroplasty Register (DHR) is to continuously monitor and improve the quality of treatment of primary and revision total hip arthroplasty (THA) in Denmark.

Study population: The DHR is a Danish nationwide arthroplasty register established in January 1995. All Danish orthopedic departments - both public and private - report to the register, and registration is compulsory.

Main variables: The main variables in the register include civil registration number, indication for primary and revision surgery, operation date and side, and postoperative complications. Completeness of primary and revision surgery is evaluated annually and validation of a number of variables has been carried out.

Descriptive data: A total of 139,525 primary THAs and 22,118 revisions have been registered in the DHR between January 1, 1995 and December 31, 2014. Since 1995, completeness of procedure registration has been high, being 97.8% and 92.0% in 2014 for primary THAs and revisions, respectively. Several risk factors, such as comorbidity, age, specific primary diagnosis and fixation types for failure of primary THAs, and postoperative complications, have been identified through the DHR. Approximately 9,000 primary THAs and 1,500 revisions are reported to the register annually.

Conclusion: The DHR is important for monitoring and improvement of treatment with THA and is a valuable tool for research in THA surgery due to the high quality of prospective collected data with long-term follow-up and high completeness. The register can be used for population-based epidemiology studies of THA surgery and can be linked to a range of other national databases.

Keywords: Danish Hip Arthroplasty Register; completeness; validation.

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Type of operation in primary total hip arthroplasty.
Figure 2
Figure 2
Surveillance graph of all primary total hip arthroplasties (n=139,295). Abbreviation: CI, confidence interval.

References

    1. Lucht U. The Danish Hip Arthroplasty Register. Acta Orthop Scand. 2000;5(71):433–439.
    1. Danish Hip Arthroplasty Register: Annual Report 2015. [Accessed April 16, 2015]. Available from: .
    1. Pedersen A, Johnsen S, Overgaard S, Soballe K, Sorensen HT, Lucht U. Registration in the Danish Hip Arthroplasty Registry: completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. Acta Orthop Scand. 2004;75(4):434–441.
    1. Nikolajsen L, Brandsborg B, Lucht U, Jensen TS, Kehlet H. Chronic pain following total hip arthroplasty: a nationwide questionnaire study. Acta Anaesthesiol Scand. 2006;50(4):495–500.
    1. Pedersen AB, Johnsen SP, Overgaard S, Soballe K, Sorensen HT, Lucht U. Total hip arthroplasty in Denmark: incidence of primary operations and revisions during 1996–2002 and estimated future demands. Acta Orthop. 2005;76(2):182–189.
    1. Pedersen AB, Johnsen SP, Overgaard S, Soballe K, Sorensen HT, Lucht U. Regional variation in incidence of primary total hip arthroplasties and revisions in Denmark, 1996–2002. Acta Orthop. 2005;76(6):815–822.
    1. Johnsen SP, Sorensen HT, Lucht U, Soballe K, Overgaard S, Pedersen AB. Patient-related predictors of implant failure after primary total hip replacement in the initial, short- and long-terms. A nationwide Danish follow-up study including 36,984 patients. J Bone Joint Surg Br. 2006;88(10):1303–1308.
    1. Pedersen AB, Mehnert F, Johnsen SP, Sorensen HT. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br. 2010;92(7):929–934.
    1. Pedersen AB, Mehnert F, Sorensen HT, Emmeluth C, Overgaard S, Johnsen SP. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice. Bone Joint J. 2014;96-B(4):479–485.
    1. Pedersen AB, Sorensen HT, Mehnert F, Johnsen SP, Overgaard S. Effectiveness and safety of different duration of thromboprophylaxis in 16,865 hip replacement patients – a real-word, prospective observational study. Thromb Res. 2015;135(2):322–328.
    1. Gundtoft PH, Overgaard S, Schonheyder HC, Moller JK, Kjaersgaard-Andersen P, Pedersen AB. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties. Acta Orthop. 2015;86(3):326–334.
    1. Glassou EN, Pedersen AB, Hansen TB. Risk of re-admission, reoperation, and mortality within 90 days of total hip and knee arthroplasty in fast-track departments in Denmark from 2005 to 2011. Acta Orthop. 2014;85(5):493–500.
    1. Varnum C, Pedersen AB, Kjaersgaard-Andersen P, Overgaard S. Comparison of the risk of revision in cementless total hip arthroplasty with ceramic-on-ceramic and metal-on-polyethylene bearings. Acta Orthop. 2015;86(4):477–484.
    1. Deleuran T, Vilstrup H, Overgaard S, Jepsen P. Cirrhosis patients have increased risk of complications after hip or knee arthroplasty. Acta Orthop. 2015;86(1):108–113.
    1. Havelin LI, Robertsson O, Fenstad AM, Overgaard S, Garellick G, Furnes O. A Scandinavian experience of register collaboration: the Nordic Arthroplasty Register Association (NARA) J Bone Joint Surg Am. 2011;93(Suppl 3):13–19.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe